La Jolla, CA, United States of America

Michael Rapp

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Rapp: Innovator in Flow Cell Technology

Introduction

Michael Rapp is a notable inventor based in La Jolla, California. He has made significant contributions to the field of flow cell technology, which is essential for various applications in scientific research and diagnostics. His innovative approach has led to the development of a unique patent that enhances the functionality of flow cells.

Latest Patents

Michael Rapp holds a patent for "Flow cells with patterned bonding regions." This invention features a flow cell that includes a patterned substrate with an active region and a bonding region that partially surrounds the active region. The active region consists of first depressions defined in a layer of the patterned substrate, along with surface chemistry positioned in these depressions. Additionally, the bonding region contains second depressions and interstitial regions, with an adhesive positioned over these areas. This design allows for a flow channel to be defined between a portion of the cover and the active region, improving the efficiency of flow cells.

Career Highlights

Michael Rapp is currently employed at Illumina Corporation, a leading company in the field of genomics and biotechnology. His work at Illumina has allowed him to contribute to advancements in DNA sequencing and analysis technologies. With a focus on innovation, he continues to push the boundaries of what is possible in his field.

Collaborations

Michael has collaborated with talented individuals such as Casey Scott Irvin and Jonathan Ziebarth. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Michael Rapp's contributions to flow cell technology exemplify the spirit of innovation in the scientific community. His patent and work at Illumina Corporation highlight his commitment to advancing technology for the betterment of research and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…